A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
Clarke, Jennifer L., Molinaro, Annette M., Cabrera, Juan R., DeSilva, Ashley A., Rabbitt, Jane E., Prey, Joshua, Drummond, Daryl C., Kim, Jaeyeon, Noble, Charles, Fitzgerald, Jonathan B., Chang, Susan M., Butowski, Nicholas A., Taylor, Jennie W., Park, John W., Prados, Michael D.
Published in Cancer chemotherapy and pharmacology (01.03.2017)
Published in Cancer chemotherapy and pharmacology (01.03.2017)
Get full text
Journal Article
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma
Clarke, Jennifer L, Molinaro, Annette M, Phillips, Joanna J, Butowski, Nicholas A, Chang, Susan M, Perry, Arie, Costello, Joseph F, DeSilva, Ashley A, Rabbitt, Jane E, Prados, Michael D
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Get full text
Journal Article
A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas
Clarke, Jennifer Leigh, Molinaro, Annette M, DeSilva, Ashley A, Rabbitt, Jane E, Drummond, Daryl C., Chang, Susan Marina, Butowski, Nicholas A., Prados, Michael
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib, and bevacizumab for initial treatment of glioblastoma (GBM)
Clarke, Jennifer Leigh, Molinaro, Annette M, Butowski, Nicholas A., Chang, Susan Marina, Phillips, Joanna J, Costa, Bruno M, Costello, Joseph F, Rabbitt, Jane E, Kivett, Valerie A, DeSilva, Ashley A, Prados, Michael
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article